New trial data showed CagriSema led to “superior” weight loss, but at a rate much less than original expectations of 25%.
Source: MarketWatch
Monday, 10. March 2025
Share:
10. March 2025 12:59
Ozempic parent’s new weight-loss drug works better, but not quite good enough
